CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment

NCT00642135 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

80

Enrollment

OTHER

Sponsor class

Stopped The total number of patients has been reached.

Conditions

Retinal Anomalies
Premature Birth

Interventions

DRUG: Mydriasert®
DRUG: phenylephrine and tropicamide eyedrops

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]